Protean eGov Share Price in Focus as Company Grants 3,39,665 Stock Options Under ESOP 2017

Protean eGov Technologies Limited has announced the grant of employee stock options under its Employee Stock Option Plan, 2017 (ESOP 2017).  

The Nomination and Remuneration Committee approved the grant on July 8, 2026, as per the SEBI regulations as per the report on exchange filings. 

Details of the Stock Options Granted 

The company has granted a total of 3,39,665 stock options to eligible employees. These options are convertible into 3,39,665 equity shares, each with a face value of ₹10.  

The exercise price for 1,78,090 stock options is set at ₹589.85, while the remaining 1,61,575 options are priced at ₹10 each. 

Vesting and Exercise Conditions 

The vesting of these options is subject to certain conditions and is scheduled to occur no earlier than 1 year and no later than 4 years from the date of grant. Once vested, employees have a period of 3 years to exercise their options. 

Regulatory Compliance and Additional Information 

The ESOP 2017 scheme is in compliance with the SEBI (SBEB) Regulations, 2021. As of now, there have been no options exercised, no money realised from the exercise of options, and no shares have arisen from the exercise of options.  

Additionally, there have been no lapses, variations, or cancellations of the terms of the options. 

Read More: Graphite India Share Price Drops as Company Decides to Shut German Divisions Amid Weak Demand! 

Protean eGov Technologies Share Price Performance 

As of July 09, 2026, at 3:30 PM, Protean eGov Technologies share price on NSE was closed at ₹579.65, up by 0.97% from the previous closing price. 

Conclusion 

Protean eGov Technologies Limited has granted 3,39,665 stock options under ESOP 2017, with exercise prices of ₹589.85 and ₹10. The options vest within 1 to 4 years, with a 3-year exercise period. 

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.